Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wheelock, V.L.
Right arrow Articles by Shoulson, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wheelock, V.L.
Right arrow Articles by Shoulson, I.
Related Collections
Right arrow All Health Services Research
Right arrow Outcome research
Right arrow All Movement Disorders
Right arrow Huntington's disease

Neurology 2003;60:998-1001
© 2003 American Academy of Neurology

Predictors of nursing home placement in Huntington disease

V.L. Wheelock, MD, T. Tempkin, RN MS, ANP, K. Marder, MD MPH, M. Nance, MD, R.H. Myers, PhD, H. Zhao, ScD, E. Kayson, RN, C. Orme and I. Shoulson, MD the Huntington Study Group*

*See the Appendix on page 1000 for a complete list of the members of the Huntington Study Group.
From the University of California Davis (Dr. Wheelock and T. Tempkin), Sacramento; Sergievsky Center and Taub Institute for Research on Alzheimer’s Disease and the Aging Brain (Dr. Marder), Columbia University, New York, NY; Hennepin County Medical Center (Dr. Nance), St. Louis Park, MN; Boston University (Dr. Myers), MA; and University of Rochester (Drs. Zhao and Shoulson, and E. Kayson and C. Orme), NY.

Address correspondence and reprint requests to Dr. Vicki L. Wheelock, University of California Davis Medical Center, 4860 Y Street, Suite 3700, Sacramento, CA 95817; e-mail: Vicki.Wheelock{at}ucdmc.ucdavis.edu

Objective: To determine whether motor, behavioral, or psychiatric symptoms in Huntington disease (HD) predict skilled nursing facility (SNF) placement.

Methods: Subjects were participants in the Huntington Study Group’s Unified Huntington Disease Rating Scale Database (Rochester, NY) between January 1994 and September 1999. Specific motor, psychiatric, and behavioral variables in subjects residing at home and in SNF were analyzed using {chi}2 and Student’s t-tests. For a subset of subjects for whom longitudinal data existed, a Cox proportional hazards model controlling for age, sex, and disease duration was used.

Results: Among 4,809 subjects enrolled, 3,070 had clinically definite HD. Of these, 228 (7.4%) resided in SNF. The SNF residents’ average age was 52 years, average disease duration was 8.6 years, and they were predominantly women (63%). The SNF residents had worse motor function (chorea, bradykinesia, gait abnormality, and imbalance, p < 0.0001); were more likely to have obsessions, compulsions, delusions, and auditory hallucinations; and had more aggressive, disruptive (p < 0.0001), and irritable behaviors (p = 0.0012). For 1,559 subjects, longitudinal data existed (average length of follow-up, 1.9 years), and 87 (5%) moved from home to SNF. In the Cox model, bradykinesia (HR 1.965, 95% CI 1.083 to 3.564), impaired gait (HR 3.004, 95% CI 1.353 to 6.668), and impaired tandem walking (HR 2.546, 95% CI 1.460 to 4.439) were predictive of SNF placement.

Conclusions: Institutionalized patients with HD are more motorically, psychiatrically, and behaviorally impaired than their counterparts living at home. However, motor variables alone predicted institutionalization. Treatment strategies that delay the progression of motor dysfunction in HD may postpone the need for institutionalization.




This article has been cited by other articles:


Home page
ptjournalHome page
M. E Busse, H. Khalil, L. Quinn, and A. E Rosser
Physical Therapy Intervention for People With Huntington Disease
Physical Therapy, July 1, 2008; 88(7): 820 - 831.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
E. van Duijn, E.M. Kingma, and R.C. van der Mast
Psychopathology in Verified Huntington's Disease Gene Carriers
J Neuropsychiatry Clin Neurosci, November 1, 2007; 19(4): 441 - 448.
[Abstract] [Full Text] [PDF]


Home page
Clin RehabilHome page
P. Zinzi, D. Salmaso, R. De Grandis, G. Graziani, S. Maceroni, A. Bentivoglio, P. Zappata, M. Frontali, and G. Jacopini
Effects of an intensive rehabilitation programme on patients with Huntington's disease: a pilot study
Clinical Rehabilitation, July 1, 2007; 21(7): 603 - 613.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by AAN Enterprises, Inc.